Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02613923 · ClinicalTrials.gov registry record · NA
A Sleep Intervention to Improve Outcomes Among Women at High Risk of Breast Cancer
A NA study, sponsored by Case Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 17
- Enrollment target
NCT02613923 is a NA study that has completed, run by Case Comprehensive Cancer Center. The registered enrollment target is 17 participants.
The verdict
NCT02613923, a NA study, has completed, sponsored by Case Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
Study Summary
Participants are asked to participate in a research study of the effect of a sleep intervention on improving sleep habits and reducing their risk of breast cancer. Participants are asked to participate in this research study because they have been identified as being at higher than average risk of developing breast cancer. The purpose of this study is to compare women who get a sleep intervention to women who do not get a sleep intervention. This study team will compare these two groups of women to see if the sleep intervention improves their sleep and if it lowers markers of inflammation that have been associated with an increased risk of breast cancer.
Interventions
- PROCEDURE Blood Draw
- BEHAVIORAL GO! To Sleep
- BEHAVIORAL Sleep information
- OTHER Pittsburgh Sleep Quality Index (PSQI)
- OTHER Insomnia Severity Index (ISI)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2015-08-04 |
| Est. Completion | 2017-07-23 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02613923
The ClinicalTrials.gov registry entry for NCT02613923 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Case Comprehensive Cancer Center, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Blood Draw is the first listed.
NCT02613923 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02613923 about?
NCT02613923 is a clinical study titled "A Sleep Intervention to Improve Outcomes Among Women at High Risk of Breast Cancer". Participants are asked to participate in a research study of the effect of a sleep intervention on improving sleep habits and reducing their risk of breast cancer. Participants are asked to participate in this research study because they have been identified as being at higher than average risk of ...
What is the current status of trial NCT02613923?
This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2015-08-04. Estimated completion is 2017-07-23.
What interventions are being tested in trial NCT02613923?
The interventions under investigation include: Blood Draw (PROCEDURE), GO! To Sleep (BEHAVIORAL), Sleep information (BEHAVIORAL), Pittsburgh Sleep Quality Index (PSQI) (OTHER), Insomnia Severity Index (ISI) (OTHER).
Who is sponsoring clinical trial NCT02613923?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.